Financhill
Back

Perspective Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.

Perspective Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.5 Buy
20-day SMA: 2.68 Sell
50-day SMA: 2.49 Buy
200-day SMA: 3.04 Sell
8-day EMA: 2.56 Buy
20-day EMA: 2.61 Buy
50-day EMA: 2.67 Buy
200-day EMA: 3.43 Sell

Perspective Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 51.94 Buy
Chaikin Money Flow: 474185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.538 - 2.838) Sell
Bollinger Bands (100): (2.2688 - 3.5888) Sell

Perspective Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Perspective Therapeutics, Inc. Stock

Is Perspective Therapeutics, Inc. Stock a Buy?

CATX Technical Analysis vs Fundamental Analysis

Sell
37
Perspective Therapeutics, Inc. (CATX) is a Sell

Is Perspective Therapeutics, Inc. a Buy or a Sell?

Perspective Therapeutics, Inc. Stock Info

Market Cap:
200M
Price in USD:
2.6700
Share Volume:
1.2M

Perspective Therapeutics, Inc. 52-Week Range

52-Week High:
5.3881
52-Week Low:
1.6000
Sell
37
Perspective Therapeutics, Inc. (CATX) is a Sell

Perspective Therapeutics, Inc. Share Price Forecast

Is Perspective Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Perspective Therapeutics, Inc.

Is Perspective Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.17 per share.

Technical Analysis of Perspective Therapeutics, Inc.

Should I short Perspective Therapeutics, Inc. stock?

* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.